Many cost drivers make funding prescription drugs an ongoing challenge for workers’ compensation claims payers. The speakers will examine prominent cost drivers, including inflation specific to drugs often prescribed to injured workers, a changing generic drug market, so-called “new” opioids, rogue pharma CEOs, specialty drugs, and aging workers. Then they will provide strategies payers may apply to manage rising costs. You will also explore applying formularies, step-therapy, guidelines, generic maximization, and pre-MSA drug-cost mitigation.